JMP Securities Upgrades Myriad Genetics, Says 'Revised Guidance Lowers The Bar'
February 04, 2015 at 12:03 PM EST
JMP Securities upgraded Myriad Genetics, Inc. (NASDAQ: MYGN) from Market Perform to Market Outperform and established a $50 price ...
